MODIFIZIERTES HLA-B57 MIT ERHÖHTER EXPRESSION

European patent · EP4380595 · In force

Register entry

Publication number
EP4380595
Application number
EP22761217
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 5, 2022
Published
Jun 12, 2024
Granted
Oct 1, 2025
Protection ends at the latest
Aug 4, 2042
Next annual fee due
Aug 31, 2027
IPC classes
A61K 39/395 (2006.01)
A61K 38/17 (2006.01)
A61P 35/00 (2006.01)
C07K 14/74 (2006.01)
C07K 16/28 (2006.01)
Priority
EP 21190004 05.08.2021
EP 21190005 05.08.2021
EP 21207324 09.11.2021
PCT application
PCT/EP2022/072131 05.08.2022
PCT publication
WO2023/012348 09.02.2023
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Aug 12, 2026

    Change

    Published in Swissreg on 12.08.2026

  3. Oct 1, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 01.10.2025

Parties

Holder

ImmunOs Therapeutics AG in Liquidation

ImmunOs Therapeutics AG

Wagistrasse 14, 8952 Schlieren

In liquidation

Inventor

MARROQUIN BELAUNZARAN, Osiris

8952 Schlieren

RENNER, Christoph

8952 Schlieren

VOGT, Lorenz

8952 Schlieren

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.